Clinical trial
Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer
NCT06458413
Study timeline
Study start (actual)2024-06-05Date precision: day
Registry last updated2024-06-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancer Recurrentunresolved
Interventions
Sponsors & collaborators
Min Yan, MDlead sponsor
Beijing Biostar Pharmaceuticals Co., Ltd.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06458413 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.